Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
5.
Clin Exp Dermatol ; 47(3): 578-580, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34610172

ABSTRACT

The COVID-19 pandemic required people to confine themselves to their homes where possible, and disrupted normal hospital activities. We examine whether this lockdown generated changes in the size of the tumours. We compared the dimensions of the surgically removed malignant skin tumours from the first 150 patients treated after the confinement ended in Spain (22 May 2020) with those of the last 150 patients to receive such treatment before the confinement began (13 March 2020). Data on tumour surface area were collected from pathology reports. Overall, no significant difference was seen in the tumour sizes. However, among men, the tumours removed after confinement were significantly larger (P < 0.05). Controversy exists over how the reduction in the number of tumours diagnosed during lockdowns might have influenced the characteristics of tumours. In this study, no overall difference was seen in the size of the tumours removed, although those removed from men after confinement were larger.


Subject(s)
Quarantine , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Aged , COVID-19 , Carcinoma, Basal Cell/pathology , Carcinoma, Basal Cell/surgery , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , Female , Humans , Male , Melanoma/pathology , Melanoma/surgery , Pandemics
6.
J Healthc Qual Res ; 36(5): 269-274, 2021.
Article in Spanish | MEDLINE | ID: mdl-34053882

ABSTRACT

BACKGROUND AND OBJECTIVE: Patient satisfaction has become one of the most important outcome measures of quality of care. This study aimed to present the translation, cultural adaptation and validation of a Spanish version of the Patient Satisfaction Questionnaire (PSQ-18) in a sample of Spanish dermatology patients. METHODS: Cross-cultural linguistic adaptation and translation-backtranslation processes were performed following accepted international guidelines. The psychometric properties, reliability and construct validity were evaluated with Cronbach's alpha and confirmatory factorial analysis respectively. The intraclass correlation coefficient was calculated in a test-retest study, which was conducted on randomly selected participants twice with a 14-21 days interval. RESULTS: 240 participants completed the cross-culturally adapted Spanish questionnaire agreed by the researchers. Internal consistency was high (Cronbach's alpha coefficient of 0.834) and confirmatory factorial analysis showed a good model fitting to the model proposed in the original version of the scale. The intraclass correlation coefficients for all the items on the questionnaire were higher than 0.8. CONCLUSIóN: PSQ-18 proved to be a valid and reliable instrument, with psychometric properties suitable for the assessment of satisfaction among dermatology patients.


Subject(s)
Dermatology , Patient Satisfaction , Cross-Cultural Comparison , Humans , Reproducibility of Results , Surveys and Questionnaires
8.
Actas dermo-sifiliogr. (Ed. impr.) ; 111(8): 665-670, oct. 2020. tab, graf
Article in Spanish | IBECS | ID: ibc-197152

ABSTRACT

ANTECEDENTES: Las redes sociales se han convertido en una herramienta clave para la búsqueda y difusión de información médica. OBJETIVO: Describir las características de las páginas relacionadas con la dermatitis atópica en las redes sociales, la temática de sus publicaciones y el grado de seguimiento que se realiza de ellas. MATERIAL Y MÉTODOS: Se seleccionaron páginas, grupos o cuentas relacionadas con la dermatitis atópica en Facebook, Twitter y Linkedin durante los meses de enero y febrero de 2020. De cada una de ellas se recogieron: el país de origen, año de creación, objetivo, presencia de enlaces a páginas web, existencia de correo electrónico y número de seguidores. Además, se realizó un análisis de las temáticas más frecuentes en las últimas publicaciones de las páginas con más seguidores de cada red social. RESULTADOS: Se incluyeron en el estudio un total de 257 páginas, grupos o cuentas (171 en Facebook, 59 en Twitter y 27 en Linkedin). Facebook obtuvo un mayor número medio (±DT) y total de seguidores (1416,71±3722,63). Los grupos de apoyo a pacientes fueron el tipo de página más frecuente (63%), aunque aquellas clasificadas como empresas o venta de productos obtuvieron un mayor número de seguidores (p < 0,035). Se analizaron 909 publicaciones, siendo «Información general sobre dermatitis atópica» la temática más frecuente (27,94% del total). CONCLUSIONES: Nuestros hallazgos ponen de manifiesto la importancia de definir claramente el papel y las limitaciones de estas plataformas para orientar futuras campañas de información y desarrollar nuevos modelos centrados en el paciente con dermatitis atópica


BACKGROUND: Social networks have become key tools for finding and disseminating medical information. OBJECTIVE: To describe the characteristics of social network postings on atopic dermatitis, the content that is posted, and the number of followers of pages, groups, or accounts. MATERIAL AND METHODS: We selected pages, groups, or accounts related to atopic dermatitis on Facebook, Twitter, and Linkedin during January and February of 2020. For each site, group, or account we recorded country of origin, year created, purpose, presence of links, provision of a contact email, and number of followers. We also analyzed the topics treated in recent content posts on the pages with the largest numbers of followers in each network. RESULTS: A total of 257 pages, groups, or accounts were included: Facebook, 171; Twitter, 59; and LinkedIn, 27. Facebook had the largest total number of pages and mean (SD) number of followers: 1416.71 (3722.63). Patient support groups accounted for most of the pages (63%), but businesses or product offers had more followers (P <.035). Of the 909 posts of informative content we analyzed, the most frequent topic was "general information about atopic dermatitis" (27.94%). CONCLUSIONS: Our findings show the importance of clearly defining the roles and limitations of social media platforms for designing future information campaigns and new patient-centered approaches to reaching patients with atopic dermatitis


Subject(s)
Online Social Networking , Dermatitis, Atopic , Consumer Health Information/statistics & numerical data , Cross-Sectional Studies , Statistics, Nonparametric , Time Factors
10.
Actas Dermosifiliogr (Engl Ed) ; 111(8): 665-670, 2020 Oct.
Article in English, Spanish | MEDLINE | ID: mdl-32574712

ABSTRACT

BACKGROUND: Social networks have become key tools for finding and disseminating medical information. OBJECTIVE: To describe the characteristics of social network postings on atopic dermatitis, the content that is posted, and the number of followers of pages, groups, or accounts. MATERIAL AND METHODS: We selected pages, groups, or accounts related to atopic dermatitis on Facebook, Twitter, and Linkedin during January and February of 2020. For each site, group, or account we recorded country of origin, year created, purpose, presence of links, provision of a contact email, and number of followers. We also analyzed the topics treated in recent content posts on the pages with the largest numbers of followers in each network. RESULTS: A total of 257 pages, groups, or accounts were included: Facebook, 171; Twitter, 59; and LinkedIn, 27. Facebook had the largest total number of pages and mean (SD) number of followers: 1416.71 (3722.63). Patient support groups accounted for most of the pages (63%), but businesses or product offers had more followers (P <.035). Of the 909 posts of informative content we analyzed, the most frequent topic was "general information about atopic dermatitis" (27.94%). CONCLUSIONS: Our findings show the importance of clearly defining the roles and limitations of social media platforms for designing future information campaigns and new patient-centered approaches to reaching patients with atopic dermatitis.


Subject(s)
Dermatitis, Atopic , Social Media , Cross-Sectional Studies , Humans , Social Networking
14.
Acta pediatr. esp ; 76(1/2): 18-19, ene.-feb. 2018. ilus
Article in Spanish | IBECS | ID: ibc-172420

ABSTRACT

La acropustulosis infantil es una entidad poco frecuente en Pediatría. Aparece habitualmente en niños menores de 2 años y se caracteriza por brotes de pápulas eritematosas muy pruriginosas que se convierten en vesículas o pústulas, fundamentalmente en zonas acrales (dorso de las manos y los pies). Habitualmente se resuelven de manera espontánea y requieren únicamente tratamiento sintomático. Presentamos el caso de un paciente varón de 6 meses diagnosticado de acropustulosis infantil con resolución espontánea (AU)


Infantile acropustulosis is a rare entity in Pediatrics. It usually appears in children under 2 years of age and it is characterized by pruritic erythematous papules that turn into vesicles or pustules; mainly in acral areas (back of the hands and feet). Acropustulosis usually resolves spontaneously and requires only symptomatic treatment. We present the case of a six-month-old boy diagnosed with childhood acropustulosis with spontaneous resolution (AU)


Subject(s)
Humans , Male , Infant , Acute Generalized Exanthematous Pustulosis/diagnosis , Acute Generalized Exanthematous Pustulosis/drug therapy , Blister/diagnosis , Scabies/diagnosis , Eosinophils , Dermis/cytology , Dermis/pathology , Diagnosis, Differential , Dapsone/therapeutic use , Vitamin D/therapeutic use
17.
Clin Exp Dermatol ; 42(4): 403-405, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28247460

ABSTRACT

Urticarial vasculitis (UV) is a mainly leucocytoclastic vasculitis with urticarial plaques. Treating these patients is challenging as the available treatments have poor efficacy. Oral corticosteroids are considered the first-line treatment, but H1 antihistamines, dapsone, colchicine, antimalarials, ciclosporin and antileucotrienes have all been tried also. However, because of their adverse effects and/or lack of efficacy, new agents are still needed. Omalizumab, an anti-IgE antibody, shows efficacy in chronic spontaneous urticaria, and might also be a good treatment for angio-oedema and urticarial vasculitis. To our knowledge, there have been only seven relevant case reports published in the English literature. We add a new case of severe chronic recurrent urticarial vasculitis refractory to all of the drugs mentioned above. We started the patient on subcutaneous omalizumab 300 mg every 4 weeks, which produced clinical improvement within the first month and total remission in the fifth month. The patient has remained stable for 23 months, and follow-up is ongoing.

19.
Pediatr. aten. prim ; 18(69): 55-58, ene.-mar. 2016. ilus
Article in Spanish | IBECS | ID: ibc-152278

ABSTRACT

En ocasiones, los brotes de dermatitis atópica pueden ser graves y de difícil control, resistentes a los tratamientos habituales. En estos casos podemos recurrir al empleo de curas húmedas, un procedimiento con buenos resultados y escasos efectos secundarios. Presentamos una serie de casos de cinco pacientes con brotes moderados-graves resistentes al tratamiento convencional, tratados mediante curas húmedas con betametasona o propionato de fluticasona diluidos al 10% en la crema hidratante durante un intervalo de tiempo de entre 4-6 días. Se obtuvo la resolución completa del brote en cuatro casos, continuándose en el caso restante las curas de forma domiciliaria durante 2-3 días más, con posterior resolución completa. Ningún paciente presentó efectos adversos (AU)


Occasionally, atopic dermatitis outbreaks can be severe and difficult to control, resistant to standard treatments. In these cases we can use wet wraps, a procedure with good results and few side effects. We present five patients with moderate to severe outbreaks resistant to conventional treatment treated with wet wraps with betamethasone or fluticasone propionate 10% diluted for 4-6 days. Complete resolution was obtained in four cases, the last one continued by domiciliary wet wraps for 2-3 days with final complete resolution. Any patient had adverse effects (AU)


Subject(s)
Child, Preschool , Child , Humans , Dermatitis, Atopic/therapy , Adrenal Cortex Hormones/therapeutic use , Betamethasone/therapeutic use , Fluticasone/therapeutic use , Histamine Antagonists/therapeutic use , Administration, Topical , Mometasone Furoate/therapeutic use , Staphylococcus aureus/isolation & purification , Superinfection/complications , Superinfection/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...